Table 2.
Analysis of SCAMP1 expression in GC tissues and associated clinicopathological factors
| Characteristics | SCAMP1 | P value | |
|---|---|---|---|
| Low | High | ||
| Age, years | 0.207 | ||
| <65 | 30 | 51 | |
| ≥65 | 12 | 34 | |
| Gender | 0.926 | ||
| Male | 29 | 58 | |
| Female | 13 | 27 | |
| Size, cm | 0.028* | ||
| ≤4cm | 19 | 22 | |
| >4cm | 23 | 63 | |
| Tumor location | 0.298 | ||
| Upper third | 6 | 15 | |
| Middle third | 5 | 9 | |
| Lower third | 26 | 40 | |
| More than 2/3 stomach | 5 | 21 | |
| Tumor stage (Depth of invasion) | 0.269 | ||
| T1-T2 | 1 | 7 | |
| T3-T4 | 41 | 78 | |
| Lymph node metastasis | 0.015* | ||
| Negative | 15 | 14 | |
| Positive | 27 | 71 | |
| TNM stage | 0.266 | ||
| I | 1 | 3 | |
| II | 14 | 17 | |
| III | 27 | 65 | |
| Lauren type | 0.583 | ||
| Intestinal | 9 | 22 | |
| Diffuse | 33 | 63 | |
pTNM stage is defined using the American Joint Committee on Cancer (AJCC) Staging System, 8th Edition. Asterisk stands for P value as follows: *, P < 0.05.